Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDConmed Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | $0.81 | $0.83 | $0.82 |
| Q2 2026 | 4 | $1.08 | $1.10 | $1.09 |
| Q3 2026 | 1 | $1.03 | $1.06 | $1.05 |
| Q4 2026 | 2 | $1.39 | $1.42 | $1.40 |
| Q1 2027 | 2 | $1.00 | $1.02 | $1.01 |
| Q2 2027 | 1 | $1.22 | $1.24 | $1.23 |
| Q3 2027 | 1 | $1.17 | $1.20 | $1.19 |
| Q4 2027 | 2 | $1.51 | $1.54 | $1.53 |
Conmed Corp. Earnings Date And Information
Conmed Corp. last posted its earnings results on Wednesday, January 28th, 2026. The company reported $1.43 earnings per share for the quarter, topping analysts' consensus estimates of $1.32 by $0.11. The company had revenue of 373.20 M for the quarter and had revenue of 1.37 B for the year. Conmed Corp. has generated $2 earnings per share over the last year ($1.51 diluted earnings per share) and currently has a price-to-earnings ratio of 29.71. Conmed Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Conmed Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/17/2026 | Q4 2025 | N/A | $0.54 | N/A | $366.88 M | $373.20 M |
| 11/06/2025 | Q3 2025 | N/A | $0.09 | N/A | $336.39 M | $337.93 M |
| 07/31/2025 | Q2 2025 | N/A | $0.69 | N/A | $338.35 M | $342.35 M |
| 05/01/2025 | Q1 2025 | N/A | $0.19 | N/A | $313.40 M | $321.26 M |
| 02/18/2025 | Q4 2024 | N/A | $1.09 | N/A | $341.00 M | $345.94 M |
| 10/31/2024 | Q3 2024 | N/A | $1.59 | N/A | $317.78 M | $316.70 M |
| 08/01/2024 | Q2 2024 | N/A | $0.97 | N/A | $334.39 M | $332.10 M |
| 04/25/2024 | Q1 2024 | N/A | $0.64 | N/A | $306.75 M | $312.27 M |
| 02/28/2024 | Q4 2023 | N/A | $1.08 | N/A | N/A | $327.05 M |
| 10/26/2023 | Q3 2023 | N/A | $0.52 | N/A | N/A | $304.58 M |
| 07/27/2023 | Q2 2023 | N/A | $0.45 | N/A | N/A | $317.65 M |
| 04/27/2023 | Q1 2023 | N/A | $0.06 | N/A | N/A | $295.47 M |
| 02/21/2023 | Q4 2022 | N/A | $0.87 | N/A | N/A | $250.87 M |
| 10/27/2022 | Q3 2022 | N/A | $1.51 | N/A | N/A | $275.09 M |
| 07/28/2022 | Q2 2022 | N/A | -$5.65 | N/A | N/A | $277.19 M |
| 05/05/2022 | Q1 2022 | N/A | $0.43 | N/A | N/A | $242.33 M |
| 02/22/2022 | Q4 2021 | N/A | $0.83 | N/A | N/A | $273.97 M |
| 10/28/2021 | Q3 2021 | N/A | $0.51 | N/A | N/A | $248.83 M |
| 07/29/2021 | Q2 2021 | N/A | $0.46 | N/A | N/A | $255.16 M |
| 04/29/2021 | Q1 2021 | N/A | $0.34 | N/A | N/A | $232.68 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Conmed Corp. Earnings: FAQ's
In the previous quarter, Conmed Corp. (:CNMD) reported $1.43 earnings per share (EPS) to beat the analysts' consensus estimate of $1.32 by $0.11.
The conference call for Conmed Corp.'s latest earnings report can be listened to online.
The conference call transcript for Conmed Corp.'s latest earnings report can be read online.
Conmed Corp. (:CNMD) has a recorded annual revenue of $1.37 B.
Conmed Corp. (:CNMD) has a recorded net income of $47.06 M.Conmed Corp. has generated $1.52 earnings per share over the last four quarters.
Conmed Corp. (:CNMD) has a price-to-earnings ratio of 29.71 and price/earnings-to-growth ratio is -1.11.